Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Rifadin Capsules 150mg*


Contraindicated
Risk of maternal and neonatal hemorrhage

Contraindicated
Rifadin Capsules 150mg* :
Type Medicine Non Marketed
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Responsible Party Gruppo Lepetit (Milano)
Origin Italy
Manufacturer Gruppo Lepetit
Origin Italy
ATC J04AB02

Your comment will appear shortly after approval

Rifadin Capsules 150mg* :

Revision Date : 05/01/2018


Effect Frequency
Abdominal bloating (Meteorism) Not known
Abdominal pain Not known
Agranulocytosis Not known
ALT increased Common
Anaphylactic reactions Not known
Anaphylactic shock Not known
AST increased Common
Blood bilirubin increased Common
Blood creatinine increased Not known
Blood pressure increased Not known
Bone pain Not known
Chromaturia Not known
Color changes of teeth Not known
Decreased appetite Not known
Dermatitis allergic Not known
Diarrhoea (Diarrhea) Uncommon
Disseminated intravascular coagulation Not known
DRESS (Drug reaction with eosinophilia and systemic symptoms) Not known
Dyspnoea (dyspnea) Not known
Eosinophilia Not known
Erythema multiforme Not known
Fetal-maternal hemorrhage Not known
Flu Syndrome Not known
Haemolytic anemia Not known
Hepatic enzyme increased Not known
Hepatitis Not known
Hyperbilirubinaemia Not known
Hypereosinophilia Not known
Hypersensitivity reactions Not known
Leucopenia (Leukopenia) Uncommon
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Menstrual disorder Not known
Muscle weakness Not known
Myopathy Not known
Nausea Common
Oedema Not known
Phlegm discoloured Not known
Porphyria Not known
Postpartum hemorrhage Not known
Pruritus Not known
Pseudomembranous colitis Not known
Psychiatric disorders Not known
Purpura Not known
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Not known
Renal tubular necrosis Not known
Respiratory disorder Not known
Shock Not known
Stevens-Johnson syndrome Not known
Sweat discolouration Not known
Tear discoloration Not known
Thrombocytopenia (Thrombopenia) Common
Tubulointerstitial nephritis Not known
Urticaria Not known
Vasculitides Not known
Vomiting Common

Different Units By MoH Code

Rifadin Capsules 150mg*  MoH 3083 :
Form Capsule, hard
Package Size Box of 8
Strength 150mg
NSSF ✘
Quarantine ✘
Reg. Number 18478
Submission date 01/01/1969
Registration Year 1969
Archived Date 2014


Price Comparison

● Country: The Netherlands
● Package Size: 8
● Public Price: 10.01 EUR ( 969,728.76 LBP )
● Pack size unit used: 8
● Cost/Unit: 1,2512 EUR ( 96,876.00 LBP )
● Pharmacy Price: 3.01 EUR ( 291596.76 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 8
● Public Price: 8 QAR ( 196,464.00 LBP )
● Pack size unit used: 8
● Cost/Unit: 1 QAR ( 24,558.00 LBP )
● Pharmacy Price: 6.733191764 QAR ( 165353.72334031 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 100
● Public Price: 104.5 AED ( 2,524,824.50 LBP )
● Pack size unit used: 100
● Cost/Unit: 1,045 AED ( 24,161.00 LBP )
● Pharmacy Price: 84.41 AED ( 2039430.01 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 100's
● Public Price: 104.5 AED ( 2,524,824.50 LBP )
● Pack size unit used: 100
● Cost/Unit: 1,045 AED ( 24,161.00 LBP )
● Pharmacy Price: 84.41 AED ( 2039430.01 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: KSA
● Package Size: 8
● Public Price: 8 SAR ( 189,120.00 LBP )
● Pack size unit used: 8
● Cost/Unit: 1 SAR ( 23,640.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 16
● Public Price: 7 TRY ( 18,760.00 LBP )
● Pack size unit used: 16
● Cost/Unit: 0,4375 TRY ( 0.00 LBP )
● Pricing Date: 31/12/2019
● Type: Medicine Authorised

● Country: UK
● Package Size: 100
● Public Price: 18.32 GBP ( 2,082,049.68 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,1832 GBP ( 0.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Ireland
● Package Size: 100
● Public Price: 23.21 EUR ( 2,248,491.96 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,2321 EUR ( 0.00 LBP )
● Exfactory Price: 21 EUR
● Pricing Date: 09/10/2020
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 100
● Public Price: 31.24 EUR ( 3,026,406.24 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,3124 EUR ( 0.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

● Country: New Zealand
● Package Size: 100 cap
● Exfactory Price: 55.75 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info